-
[EN] PROCESS AND INTERMEDIATES FOR THE PREPARATION OF (1R, 2S, 5S)-3-AZABICYCLO[3, 1, 0]HEXANE-2-CARBOXAMIDE, N-[3-AMINO-1-(CYCLOBUTYLMETHYL)-2, 3-DIOXOPROPYL] ]-3-[(2S)-2-[[[1, 1-DIMETHYLETHYL]AMINO]CARBONYLAMINO]-3, 3-DIMETHYL-1-OXOBUTYL]-6, 6-DIMETHYL<br/>[FR] PROCEDE ET INTERMEDIAIRES POUR PREPARER DU (1R,2S,5S)-3-AZABICYCLO[3,1,0]HEXANE-2-CARBOXAMIDE, N-[3-AMINO-1-(CYCLOBUTYLMETHYL)-2,3-DIOXOPROPYL]-3-[(2S)-2-[[[1,1-DIMETHYLETHYL]AMINO]CARBONYLAMINO]-3,3-DIMETHYL-1-OXOBUTYL]-6,6-DIMETHYLE
申请人:SCHERING CORP
公开号:WO2004113294A1
公开(公告)日:2004-12-29
In one embodiment, the present application relates to a process of making a compound of formula (I): and to certain intermediate compounds that are made within the process of making the compound of formula (I).
在一个实施例中,本申请涉及制备化合物(I)的过程,以及在制备化合物(I)过程中制备的某些中间化合物。
-
[EN] PROCESS FOR THE PREPARATION OF (3S)-3-AMINO-N-CYCLOPROPYL-2-HYDROXYALKANAMIDE DERIVATIVES<br/>[FR] PROCÉDÉ DE PRÉPARATION DE DÉRIVÉS DE (3S)-3-AMINO-N-CYCLOPROPYL-2-HYDROXYALCANAMIDE
申请人:VIROBAY INC
公开号:WO2009114633A1
公开(公告)日:2009-09-17
The present invention relates to a process for the preparation of (2S,3S)-3-amino-N- cyclopropyl-2-hydroxyalkanamides, and their use in the preparation of HCV inhibitors and cathepsin inhibitors.
本发明涉及一种制备(2S,3S)-3-氨基-N-环丙基-2-羟基脂肪酰胺的方法,以及它们在制备HCV抑制剂和卡特普星抑制剂中的应用。
-
PROCESS AND INTERMEDIATES FOR THE PREPARATION OF (1R, 2S, 5S)-3- AZABICYCLO[ 3, 1, 0]HEXANE-2-CARBOXAMIDE, N- [3-AMINO -1-(CYCLOBUTYLMETHYL)-2, 3-DIOXOPROPYL] ]-3- [ (2S)- 2-[[[1, 1-DIMETHYLETHYL ]AMINO]CARBONYLA MINO ]-3, 3-DIMETHYL-1-OXOBUTYL] -6, 6-DIMETHYL
申请人:Schering Corporation
公开号:EP1641754B1
公开(公告)日:2008-03-26
-
MOSTOWICZ, D.;ABRAMSKI, W.;BELZECKI, C., POL. J. CHEM., 1981, 55, N 6, 1387-1391
作者:MOSTOWICZ, D.、ABRAMSKI, W.、BELZECKI, C.
DOI:——
日期:——
-
[EN] ASSOCIATION OF COMPOUNDS IN CARBON DIOXIDE AND THE GELS AND/OR FOAMS FORMED THEREFROM<br/>[FR] ASSOCIATION DE COMPOSES AU GAZ CARBONIQUE, GELS ET/OU MOUSSES AINSI OBTENUS
申请人:UNIV YALE
公开号:WO2000035998A2
公开(公告)日:2000-06-22
The invention relates to a method of increasing the viscosity of supercritical CO2 by combining a compound having a CO2-philic functional group and an aggregating functional group which enables the compound to form a supramolecular network in solution with supercritical CO2 to form a solution. The compound is then aggregated in solution to form a supramolecular network such that the viscosity of the supercritical CO2 with the supramolecular network is greater than that of the starting supercritical CO2. The invention also relates to a method of making a microcellular foam by combining a compound having a CO2-philic functional group and an aggregating functional group which enables the compound to form a supramolecular network in solution, with supercritical CO2 to form a solution. The compound is aggregated to form a supramolecular network in solution. Then the CO2 is removed under conditions sufficient to form a microcellular foam.